Aripiprazole Augmentation Therapy in Treatment-resistant Depression
Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
20 therapy-refractory patients with major depression will be treated for 3 weeks with
Aripiprazole 10 mg/d. Effectivity will be assessed using a pre-post comparison of different
psychopathological rating scales and patient adherence.